Literature DB >> 8502598

[Thrombolytic treatment of Budd-Chiari syndrome with portal venous thrombosis].

J Pawlak1, M Palester-Chlebowczyk, B Michałowicz, M Elwertowski, P Małkowski, J Szczerbień.   

Abstract

Own material of 7 patients is presented pathology: venous thrombosis involving both hepatic veins and portal system, resulting in severe impairment of liver function and portal circulation, leading up to a fatal end (if not treated). Neither surgical decompression nor liver transplantation is feasible from the technical point of view. Patients were treated with activators of fibrinolysis. In four cases the treatment was effective and resulted in recanalisation of the previously occluded veins. Early re-thrombosis was the reason of death in one case. One patient died 4 years later because of cerebral vascular thrombosis. Two others live over 5 years, symptom-free. The authors consider thrombolytic treatment as a life saving procedure in cases of hepatic and portal venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502598

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  1 in total

1.  Combination of thrombolytic therapy and angioplastic stent insertion in a patient with Budd-Chiari syndrome.

Authors:  Fatemi Reza; Daryani E Naser; Ganaati Hossein; Zahmatkesh Mehrdad
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.